South Korea · Delayed Price · Currency is KRW ALTEOGEN Statistics
Total Valuation
ALTEOGEN has a market cap or net worth of KRW 21.24 trillion. The enterprise value is 20.90 trillion.
| Market Cap | 21.24T |
| Enterprise Value | 20.90T |
Important Dates
The next estimated earnings date is Tuesday, August 11, 2026.
| Earnings Date | Aug 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ALTEOGEN has 69.63 million shares outstanding. The number of shares has increased by 0.99% in one year.
| Current Share Class | 69.63M |
| Shares Outstanding | 69.63M |
| Shares Change (YoY) | +0.99% |
| Shares Change (QoQ) | +0.24% |
| Owned by Insiders (%) | 25.38% |
| Owned by Institutions (%) | 10.50% |
| Float | 51.87M |
Valuation Ratios
The trailing PE ratio is 202.28 and the forward PE ratio is 60.28.
| PE Ratio | 202.28 |
| Forward PE | 60.28 |
| PS Ratio | 104.23 |
| PB Ratio | 35.00 |
| P/TBV Ratio | 42.42 |
| P/FCF Ratio | 186.38 |
| P/OCF Ratio | 141.64 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 225.00, with an EV/FCF ratio of 183.42.
| EV / Earnings | 160.54 |
| EV / Sales | 102.57 |
| EV / EBITDA | 225.00 |
| EV / EBIT | 245.41 |
| EV / FCF | 183.42 |
Financial Position
The company has a current ratio of 4.32, with a Debt / Equity ratio of 0.01.
| Current Ratio | 4.32 |
| Quick Ratio | 3.78 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.08 |
| Debt / FCF | 0.06 |
| Interest Coverage | 6.67 |
Financial Efficiency
Return on equity (ROE) is 25.22% and return on invested capital (ROIC) is 42.30%.
| Return on Equity (ROE) | 25.22% |
| Return on Assets (ROA) | 7.72% |
| Return on Invested Capital (ROIC) | 42.30% |
| Return on Capital Employed (ROCE) | 13.94% |
| Weighted Average Cost of Capital (WACC) | 9.62% |
| Revenue Per Employee | 1.18B |
| Profits Per Employee | 756.91M |
| Employee Count | 172 |
| Asset Turnover | 0.30 |
| Inventory Turnover | 12.32 |
Taxes
In the past 12 months, ALTEOGEN has paid 50.94 billion in taxes.
| Income Tax | 50.94B |
| Effective Tax Rate | 27.62% |
Stock Price Statistics
The stock price has increased by +4.23% in the last 52 weeks. The beta is 0.97, so ALTEOGEN's price volatility has been similar to the market average.
| Beta (5Y) | 0.97 |
| 52-Week Price Change | +4.23% |
| 50-Day Moving Average | 256,251.15 |
| 200-Day Moving Average | 307,601.25 |
| Relative Strength Index (RSI) | 74.05 |
| Average Volume (20 Days) | 589,598 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ALTEOGEN had revenue of KRW 203.76 billion and earned 130.19 billion in profits. Earnings per share was 1,507.80.
| Revenue | 203.76B |
| Gross Profit | 156.00B |
| Operating Income | 85.18B |
| Pretax Income | 184.42B |
| Net Income | 130.19B |
| EBITDA | 92.91B |
| EBIT | 85.18B |
| Earnings Per Share (EPS) | 1,507.80 |
Balance Sheet
The company has 447.63 billion in cash and 7.11 billion in debt, with a net cash position of 440.51 billion or 6,326.35 per share.
| Cash & Cash Equivalents | 447.63B |
| Total Debt | 7.11B |
| Net Cash | 440.51B |
| Net Cash Per Share | 6,326.35 |
| Equity (Book Value) | 606.78B |
| Book Value Per Share | 7,242.06 |
| Working Capital | 393.03B |
Cash Flow
In the last 12 months, operating cash flow was 149.94 billion and capital expenditures -35.99 billion, giving a free cash flow of 113.95 billion.
| Operating Cash Flow | 149.94B |
| Capital Expenditures | -35.99B |
| Depreciation & Amortization | 7.73B |
| Net Borrowing | -5.41B |
| Free Cash Flow | 113.95B |
| FCF Per Share | 1,636.43 |
Margins
Gross margin is 76.56%, with operating and profit margins of 41.81% and 63.89%.
| Gross Margin | 76.56% |
| Operating Margin | 41.81% |
| Pretax Margin | 90.51% |
| Profit Margin | 63.89% |
| EBITDA Margin | 45.60% |
| EBIT Margin | 41.81% |
| FCF Margin | 55.92% |
Dividends & Yields
This stock pays an annual dividend of 285.38, which amounts to a dividend yield of 0.09%.
| Dividend Per Share | 285.38 |
| Dividend Yield | 0.09% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.99% |
| Shareholder Yield | -0.90% |
| Earnings Yield | 0.61% |
| FCF Yield | 0.54% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for ALTEOGEN is 370,897.44, which is 5.97% higher than the current price. The consensus rating is "Buy".
| Price Target | 370,897.44 |
| Price Target Difference | 5.97% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (3Y) | 67.04% |
| EPS Growth Forecast (3Y) | 64.99% |
Stock Splits
The last stock split was on August 5, 2026. It was a forward split with a ratio of 1.3.
| Last Split Date | Aug 5, 2026 |
| Split Type | Forward |
| Split Ratio | 1.3 |
Scores
ALTEOGEN has an Altman Z-Score of 113.26 and a Piotroski F-Score of 6.
| Altman Z-Score | 113.26 |
| Piotroski F-Score | 6 |